Corpus ID: 22610128

[Mycophenolate mofetil in the treatment of selected connective tissue diseases].

@article{Batko2013MycophenolateMI,
  title={[Mycophenolate mofetil in the treatment of selected connective tissue diseases].},
  author={B. Batko and P. Krawiec and J. Osieleniec and W. Sułowicz},
  journal={Przeglad lekarski},
  year={2013},
  volume={70 9},
  pages={
          724-9
        }
}
Mycophenolate mofetil (MMF) is an inhibitor of inosine monophosphate dehydrogenase, which affects de novo purine synthesis and T- and B-cell proliferation. So far its efficacy and safety as an immunosuppressive treatment have been proven in organ transplantations and also in various autoimmune diseases. A literature search was conducted by using PubMed and the Cochrane library. This review focuses primarily on current treatment with MMF for systemic lupus erythematosus, systemic sclerosis… Expand

References

SHOWING 1-10 OF 108 REFERENCES
Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus
Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.
Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases.
Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis
Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis
Cyclophosphamide-intolerant Wegener's granulomatosis successfully treated with mycophenolate mofetil.
Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis
...
1
2
3
4
5
...